References
- Bagshaw SM, Hoste EA, Jacka MJ. Best evidence in critical care
medicine. Intensive vs conventional blood glucose control in
critically ill patients. Can J Anaesth. 2010; 57: 172-5.
- Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F,
Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R.
Intensive insulin therapy in the critically ill patients. N Engl J
Med. 2001; 345: 1359-67.
- Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and
increased risk of death after myocardial infarction in patients with
and without diabetes: a systematic overview. Lancet. 2000; 355: 773-8.
- Bistrian BR. Hyperglycemia and infection: which is the chicken and
which is the egg? JPEN J Parenter Enteral Nutr. 2001; 25: 180-1.
- Coşkun R, Gündoğan K, Güven M, Sungur M. Efficacy of an insulin
infusion treatment protocol administered in a medical intensive care
unit. J Crit Intensive Care. 2012; 1: 9-12.
- Qaseem A, Chou R, Humphrey LL, Shekelle P, Clinical Guidelines
Committee of the AmericaN College of P. Inpatient glycemic control:
best practice advice from the Clinical Guidelines Committee of the
American College of Physicians. Am J Med Qual. 2014; 29(2):
95-8.
- American Diabetes Associadion. Diabetes care in the hospital:
standards of medical care in diabetes-2019. Diabetes Care. 2019;
42(Suppl 1): 173-81.
- Bilotta F, Badenes R, Lolli S, Belda FJ, Einav S, Rosa G. Insulin
infusion therapy in critical care patients: regular insulin vs
short-acting insulin. A prospective, crossover, randomized,
multicenter blind study. J Crit Care . 2015; 30(2):437.e1-6.
- Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F,
Crucitti F. Insulin adsorption to three‐liter ethylen vinyl acetate
bags during 24‐hour infusion. JPEN J Parenter Enteral
Nutr. 1989; 13(5): 539-41.
- Jakobsson T, Shulman R, Gill H, Taylor K. The impact of insulin
adsorption onto the infusion sets in the adult intensive care unit. J
Diabetes Sci Technol. 2009; 3(1): 213-4.
- Ng KX, Yeo JHT, Woo FZ, Wong JPY, Sethi SK, Loh TP. Insulin adsorption
by infusion sets in the setting of treatment of hyperkalaemia. Wien
Klin Wochenschr. 2016; 128(11-12): 460-1.
- Peterson L, Caldwell J, Hoffman J. Insulin adsorbance to
polyvinylchloride surfaces with implications for constant-infusion
therapy. Diabetes. 1976; 25(1): 72-4.
- Petty C, Cunningham NL. Insulin adsorption by glass infusion bottles,
polyvinylchloride infusion containers, and intravenous
tubing. Anesthesiology. 1974; 0(4): 400-4.
- Thompson CD, Vital-Carona J, Faustino EVS. The effect of tubing dwell
time on insulin adsorption during intravenous insulin
infusions. Diabetes Technol Ther. 2012; 4(10): 912-6.
- Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin
infusion solution containers. Am J Health Syst Pharm. 2006;
63(23), 2379-82.
- Zahid N, Taylor KM, Gill H, Maguire F, Shulman R. Adsorption of
insulin onto infusion sets used in adult intensive care unit and
neonatal care settings. Diabetes Res Clin Pract. 2008; 80(3):
e11-e13.
- Goldberg PA, Kedves A, Walter K, Groszmann A, Belous A, Inzucchi SE.
”Waste Not, Want Not”: Determining the Optimal Priming Volume for
Intravenous Insulin Infusions. Diabetes Technol Ther. 2006;
8(5): 598-601.
- Kalra S, Bajwa SJ. Intravenous insulin use: technical aspects and
caveats. JPMA. 2013; 63(5): 650-3.
- Turner RE. Insulin administration for the control of blood glucose in
the adult ICU-an evidence-based guideline:
guideline. SAJCC. 2007; 23(1): 24-30.
- Turkish Pharmacopoeia. Turkish Medicines and Medical Devices Agency;
Place, 2017.
- Guideline IHT. (2005). Validation of analytical procedures: text and
methodology. Q2 (R1). 2005; 1: 1-15.
- Fuloria M, Friedberg MA, DuRant RH, Aschner JL. Effect of flow rate
and insulin priming on the recovery of insulin from microbore infusion
tubing. Pediatrics. 1998; 102(6): 1401–6.